Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2021 | Hummingbird Bioscience | $130.0M Series C | Ken Harrison | Frazier Healthcare Partners, Affinity Asset Advisors, Ally Bridge Group, Amgen Ventures, Droia Ventures, EDBI, Heritas Capital, Mirae Asset, Morningside Ventures, Octagon Capital, Polaris Partners, Pureos Bioventures, Kiel Kim |